<i>N</i>‐Acyl Amides from <i>Neisseria meningitidis</i> and Their Role in Sphingosine Receptor Signaling
Wooyoung Cho, Autumn G. York, Rurun Wang, Thomas P. Wyche, Grazia Piizzi, Richard A. Flavell, Jason M. Crawford
Abstract
Abstract Neisseria meningitidis is a Gram‐negative opportunistic pathogen that is responsible for causing human diseases with high mortality, such as septicemia and meningitis. The molecular mechanisms N. meningitidis employ to manipulate the immune system, translocate the mucosal and blood‐brain barriers, and exert virulence are largely unknown. Human‐associated bacteria encode a variety of bioactive small molecules with growing evidence for N ‐acyl amides as being important signaling molecules. However, only a small fraction of these metabolites has been identified from the human microbiota thus far. Here, we heterologously expressed an N ‐acyltransferase encoded in the obligate human pathogen N. meningitidis and identified 30 N ‐acyl amides with representative members serving as agonists of the G‐protein coupled receptor (GPCR) S1PR4. During this process, we also characterized two mammalian N ‐acyl amides derived from the bovine medium. Both groups of metabolites suppress anti‐inflammatory interleukin‐10 signaling in human macrophage cell types, but they also suppress the pro‐inflammatory interleukin‐17A + population in T H 17‐differentiated CD4 + T cells.